The EKZ/AMC childhood cancer survivor cohort: Methodology, clinical characteristics, and data availability

Journal of Cancer Survivorship

Volumn 7, Issue 3, 2013, Pages 439-454

  Sieswerda, E ^a   Mulder, R L ^a   van Dijk, I W E M ^a   van Dalen, E C ^a   Knijnenburg, S L ^a   van der Pal, H J H ^a   Mud, M S ^a   Heinen, R C ^a   Caron, H N ^a   Kremer, L C M ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Childhood cancer; Cohort study design; Late adverse effects; Survivors

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; COHORT ANALYSIS; EPIDEMIOLOGY; FEMALE; FOLLOW UP; HOSPITAL; HUMAN; INFORMATION RETRIEVAL; MALE; MIDDLE AGED; MORTALITY; NEOPLASM; PRESCHOOL CHILD; REGISTER; STATISTICS; SURVIVOR; UNIVERSITY HOSPITAL; YOUNG ADULT;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EPIDEMIOLOGIC RESEARCH DESIGN; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, PEDIATRIC; HUMANS; INFORMATION STORAGE AND RETRIEVAL; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; SURVIVORS; YOUNG ADULT;

EID: 84881228248     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-013-0283-9     Document Type: Article

References (50)

1. Curry HL, Parkes SE, Powell JE, et al. Caring for survivors of childhood cancers: the size of the problem. Eur J Cancer. 2006;42: 501-8.
2. Gatta G, Zigon G, Capocaccia R, et al. Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer. 2009;45: 992-1005.
3. Geenen MM, Cardous-Ubbink MC, Kremer LC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;297: 2705-15.
4. Mertens AC, Liu Q, Neglia JP, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2008;100: 1368-79.
5. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355: 1572-82.
6. Reulen RC, Winter DL, Frobisher C, et al. Long-term cause-specific mortality among survivors of childhood cancer. JAMA. 2010;304: 172-9.
7. Reulen RC, Frobisher C, Winter DL, et al. Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA. 2011;305: 2311-9.
8. Oeffinger KC, van Leeuwen FE, Hodgson DC. Methods to assess adverse health-related outcomes in cancer survivors. Cancer Epidemiol Biomarkers Prev. 2011;20: 2022-34.
9. Jaspers MW, Caron H, Behrendt H, et al. The development of a new information model for a pediatric cancer registry on late treatment sequelae in The Netherlands. Stud Health Technol Inform. 2000;77: 895-9.
10. Dutch Childhood Oncology Group. Richtlijn follow-up na kinderkanker meer dan 5 jaar na diagnose. SKION, Den Haag/Amsterdam. http://www. skion. nl (2010).
11. Cardous-Ubbink MC, Heinen RC, Langeveld NE, et al. Long-term cause-specific mortality among five-year survivors of childhood cancer. Pediatr Blood Cancer. 2004;42: 563-73.
12. Cardous-Ubbink MC, Heinen RC, Bakker PJ, et al. Risk of second malignancies in long-term survivors of childhood cancer. Eur J Cancer. 2007;43: 351-62.
13. Cardous-Ubbink MC, Geenen MM, Schade KJ, et al. Hypertension in long-term survivors of childhood cancer: a nested case-control study. Eur J Cancer. 2010;46: 782-90.
14. van der Pal HJ, van Dalen EC, van Delden DE, et al. High risk of symptomatic cardiac events in childhood cancer survivors. J Clin Oncol. 2012;30: 1429-37.
15. van Dijk IW, Oldenburger F, Cardous-Ubbink MC, et al. Evaluation of late adverse events in long-term Wilms' tumor survivors. Int J Radiat Oncol Biol Phys. 2010;78: 370-8.
16. van Dalen EC, van der Pal HJ, van den Bos C, et al. Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines. Eur J Cancer. 2006;42: 2549-53.
17. Geenen MM, Bakker PJ, Kremer LC, et al. Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy. Pediatr Blood Cancer. 2010;55: 690-7.
18. Heikens J, Michiels EM, Behrendt H, et al. Long-term neuro-endocrine sequelae after treatment for childhood medulloblastoma. Eur J Cancer. 1998;34: 1592-7.
19. Heikens J, Ubbink MC, van der Pal HP, et al. Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease. Cancer. 2000;88: 2116-21.
20. Knijnenburg SL, Jaspers MW, van der Pal HJ, et al. Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors. Clin J Am Soc Nephrol. 2012;7: 1416-27.
21. Mulder RL, Thonissen NM, van der Pal HJ, et al. Pulmonary function impairment measured by pulmonary function tests in long-term survivors of childhood cancer. Thorax. 2011;66: 1065-71.
22. Noorda EM, Somers R, van Leeuwen FE, et al. Adult height and age at menarche in childhood cancer survivors. Eur J Cancer. 2001;37: 605-12.
23. Tromp K, Claessens JJ, Knijnenburg SL, et al. Reproductive status in adult male long-term survivors of childhood cancer. Hum Reprod. 2011;26: 1775-83.
24. van der Pal HJ, van Dalen EC, Hauptmann M, et al. Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study. Arch Intern Med. 2010;170: 1247-55.
25. van Santen HM, Vulsma T, Dijkgraaf MG, et al. No damaging effect of chemotherapy in addition to radiotherapy on the thyroid axis in young adult survivors of childhood cancer. J Clin Endocrinol Metab. 2003;88: 3657-63.
26. Mulder RL, Kremer LC, Koot BG, et al. Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: prevalence and risk factors. Eur J Cancer. 2012;49: 185-93.
27. Langeveld N, Ubbink M, Smets E. 'I don't have any energy': the experience of fatigue in young adult survivors of childhood cancer. Eur J Oncol Nurs. 2000;4: 20-8.
28. Langeveld NE, Grootenhuis MA, Voute PA, et al. No excess fatigue in young adult survivors of childhood cancer. Eur J Cancer. 2003;39: 204-14.
29. Langeveld NE, Ubbink MC, Last BF, et al. Educational achievement, employment and living situation in long-term young adult survivors of childhood cancer in the Netherlands. Psychooncology. 2003;12: 213-25.
30. Langeveld NE, Grootenhuis MA, Voute PA, et al. Posttraumatic stress symptoms in adult survivors of childhood cancer. Pediatr Blood Cancer. 2004;42: 604-10.
31. Langeveld NE, Grootenhuis MA, Voute PA, et al. Quality of life, self-esteem and worries in young adult survivors of childhood cancer. Psychooncology. 2004;13: 867-81.
32. Maurice-Stam H, Grootenhuis MA, Caron HN, et al. Course of life of survivors of childhood cancer is related to quality of life in young adulthood. J Psychosoc Oncol. 2007;25: 43-58.
33. Maurice-Stam H, Oort FJ, Last BF, et al. A predictive model of health-related quality of life in young adult survivors of childhood cancer. Eur J Cancer Care (Engl). 2009;18: 339-49.
34. Maurice-Stam H, Verhoof EJ, Caron HN, et al. Are survivors of childhood cancer with an unfavourable psychosocial developmental trajectory more likely to apply for disability benefits? Psychooncology. 2011;22: 708-14.
35. Stam H, Grootenhuis MA, Last BF. The course of life of survivors of childhood cancer. Psychooncology. 2005;14: 227-38.
36. Stam H, Grootenhuis MA, Caron HN, et al. Quality of life and current coping in young adult survivors of childhood cancer: positive expectations about the further course of the disease were correlated with better quality of life. Psychooncology. 2006;15: 31-43.
37. van Dijk M, Grootenhuis MA, de Boer M, et al. Alexithymia in long-term survivors of childhood cancer. Pediatr Rehabil. 2002;5: 203-7.
38. Aronson DC, Slaar A, Heinen RC, et al. Long-term outcome of bilateral Wilms tumors (BWT). Pediatr Blood Cancer. 2011;56: 1110-3.
39. van Dijk IW, Cardous-Ubbink MC, van der Pal HJ, et al. Dose-effect relationships for adverse events after cranial radiation therapy in long-term childhood cancer survivors. Int J Radiat Oncol Biol Phys. 2013;85: 768-75.
40. Hudson MM, Ness KK, Nolan VG, et al. Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort study. Pediatr Blood Cancer. 2011;56: 825-36.
41. Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002;38: 229-39.
42. Robison LL, Armstrong GT, Boice JD, et al. The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol. 2009;27: 2308-18.
43. Hawkins MM, Lancashire ER, Winter DL, et al. The British Childhood Cancer Survivor Study: objectives, methods, population structure, response rates and initial descriptive information. Pediatr Blood Cancer. 2008;50: 1018-25.
44. McBride ML, Rogers PC, Sheps SB, et al. Childhood, adolescent, and young adult cancer survivors research program of British Columbia: objectives, study design, and cohort characteristics. Pediatr Blood Cancer. 2010;55: 324-30.
45. Kuehni CE, Rueegg CS, Michel G, et al. Cohort profile: the Swiss Childhood Cancer Survivor Study. Int J Epidemiol. 2012;41: 1553-64.
46. Stricker BH, Stijnen T. Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies. Eur J Epidemiol. 2010;25: 245-51.
47. Grimes DA, Schulz KF. Cohort studies: marching towards outcomes. Lancet. 2002;359: 341-5.
48. Laupacis A, Wells G, Richardson WS, et al. Users' guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. JAMA. 1994;272: 234-7.
49. Visscher H, Ross CJ, Rassekh SR, et al. Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol. 2012;30: 1422-8.
50. Bhatia S. Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors. Cancer Epidemiol Biomarkers Prev. 2011;20: 2048-67.